Keyphrases
Nigeria
100%
COVID-19 Pandemic
49%
Virus
42%
Vaccination
36%
COVID-19
35%
IgG Antibody
26%
Ado-Ekiti
22%
Antenatal Clinic
21%
Escherichia Coli
21%
Africa
21%
Bacterial Pathogens
20%
Pregnant Women
20%
Southwest Nigeria
20%
Teaching Hospital
20%
Bacterial Contamination
19%
Infection Risk
18%
Coronavirus Disease 2019 Vaccine
18%
Vaccine Hesitancy
17%
Ekiti
16%
Staphylococcus Aureus
15%
IgM Antibody
15%
Acceptance Rate
15%
Selling
14%
Bacterial Isolates
14%
Seroprevalence
14%
Asia
14%
South America
14%
Low-middle Income Countries
13%
Eyeglasses
13%
Chlamydia Trachomatis
13%
Tertiary Institutions
13%
Highly Active Antiretroviral Therapy (HAART)
13%
Herbal Remedies
13%
Lessons Learned
13%
Nigerians
13%
Pseudomonas Aeruginosa (P. aeruginosa)
13%
Vaccine Development
12%
Immune Response
12%
Klebsiella Pneumoniae (K. pneumoniae)
12%
Coronavirus Disease 2019 Vaccination
10%
Infectious Diseases
10%
Ready-to-eat
10%
Nigerian Population
10%
Citrobacter
10%
Vaccination Rate
10%
Ciprofloxacin
9%
Adverse Effects
8%
Pathogenic Bacteria
8%
Structured Questionnaire
8%
Thrombocytopenia
8%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
36%
Coronavirinae
34%
Infection
29%
Prevalence
29%
Infectious Agent
23%
Escherichia coli
21%
Antiinfective Agent
18%
Chlamydia Trachomatis
13%
Eye Infection
13%
HIV
13%
Citrobacter
13%
Immunoglobulin G Antibody
13%
Herbal Remedy
13%
Staphylococcus Aureus
13%
Antibiotics
11%
Pseudomonas aeruginosa
11%
Salmonella
11%
Cross-Sectional Study
10%
Thrombocytopenia
10%
Immunoglobulin M Antibody
10%
Immunoglobulin M
9%
Klebsiella pneumoniae
9%
Pandemic
8%
Citrobacter Freundii
8%
Seroprevalence
8%
Receptor
7%
Vaccine Development
7%
Enterobacter
7%
Andrographis paniculata
7%
Ciprofloxacin
7%
Vaccine Acceptance
7%
Agar
7%
Secukinumab
6%
Psoriatic Arthritis
6%
Interleukin 17
6%
Psoriasis Vulgaris
6%
Inflammation
6%
Monoclonal Antibody
6%
Sodium Fluoride
6%
Toothpaste
6%
Antiphospholipid Antibody
6%
Protein Antibody
6%
Corticosterone
6%
Ginger
6%
Human Immunodeficiency Virus Vaccine
6%
Human Papillomavirus
6%
SARS Coronavirus
6%
Aspartic Acid
6%
Blood Dyscrasia
6%
Thrombocyte Antigen
6%
Medicine and Dentistry
COVID-19
71%
Virus
30%
Infection
29%
Public Health
28%
Diseases
22%
Pandemic
20%
Cross Sectional Study
16%
Coronavirinae
15%
Human Immunodeficiency Virus
13%
Prevalence
13%
Vaccine Hesitancy
12%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Vaccine Development
10%
Flight
8%
Immunoglobulin M Antibody
8%
Seroprevalence
8%
Study Participant
7%
Vaccine Acceptance
7%
Immunoglobulin M
7%
Pathogen
6%
Tumor Microenvironment
6%
Parvovirus B19
6%
Low and Middle Income Countries
6%
Chlamydia Trachomatis
6%
Sodium Fluoride
6%
Travel Medicine
6%
Antibiogram
6%
Bacterium Contamination
6%
Human Immunodeficiency Virus Vaccine
6%
COVID-19 Vaccine
6%
Highly Active Antiretroviral Therapy
6%
Immunology
6%
Antiinfective Agent
6%
One Health
6%
Yellow Fever
6%
Neoplasm
6%
Antiviral Therapy
6%
Bone Marrow Cell
6%
Human Cytomegalovirus
6%
Cytomegalovirus Infection
6%
Disease Outbreaks
6%
Dentifrice
6%
Infectious Disease
6%
Vaccine Efficacy
6%
Medicine
5%
Agar
5%
Dental Procedure
5%
